Cargando...
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
The transcription factor NRF2 (nuclear factor erythroid 2-related factor 2) triggers the first line of homeostatic responses against a plethora of environmental or endogenous deviations in redox metabolism, proteostasis, inflammation, etc. Therefore, pharmacological activation of NRF2 is a promising...
Guardado en:
| Publicado en: | Oxid Med Cell Longev |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Hindawi
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6664516/ https://ncbi.nlm.nih.gov/pubmed/31396308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9372182 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|